DTC

Direct-to-Consumer (DTC) pharmaceutical advertising data reveals a strong alignment with the spend drivers to medicaid prescriptions. The drugs driving the highest cost and prescription volume in the public safety net are often the exact same brands backed by multi-million dollar television, digital, and print ad campaigns.

​

​Evaluating the totality of financial reimbursement in this dataset reveals that Medicaid's billions do not align linearly with the most prevalent diseases. Instead, they align heavily with the market pricing of specialty biologic innovations and high-cost metabolic management.